ChromaDex Corporation (CDXC)
NASDAQ: CDXC · IEX Real-Time Price · USD
3.540
-0.020 (-0.56%)
At close: Apr 30, 2024, 4:00 PM
3.450
-0.090 (-2.54%)
After-hours: Apr 30, 2024, 6:41 PM EDT
ChromaDex Revenue
In the year 2023, ChromaDex had annual revenue of $83.57M with 15.99% growth. Revenue in the quarter ending December 31, 2023 was $21.20M with 0.95% year-over-year growth.
Revenue (ttm)
$83.57M
Revenue Growth
+15.99%
P/S Ratio
3.20
Revenue / Employee
$788,396
Employees
106
Market Cap
267.35M USD
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 83.57M | 11.52M | 15.99% |
Dec 31, 2022 | 72.05M | 4.60M | 6.82% |
Dec 31, 2021 | 67.45M | 8.19M | 13.82% |
Dec 31, 2020 | 59.26M | 12.97M | 28.01% |
Dec 31, 2019 | 46.29M | 14.73M | 46.69% |
Dec 31, 2018 | 31.56M | 10.36M | 48.85% |
Dec 30, 2017 | 21.20M | -463.65K | -2.14% |
Dec 31, 2016 | 21.66M | 3.78M | 21.13% |
Jan 2, 2016 | 17.88M | 2.57M | 16.79% |
Jan 3, 2015 | 15.31M | 5.15M | 50.71% |
Dec 28, 2013 | 10.16M | -1.45M | -12.48% |
Dec 29, 2012 | 11.61M | 3.50M | 43.12% |
Dec 31, 2011 | 8.11M | 546.24K | 7.22% |
Jan 1, 2011 | 7.57M | 1.79M | 30.95% |
Jan 2, 2010 | 5.78M | 1.27M | 28.22% |
Jan 3, 2009 | 4.51M | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Sharecare | 445.25M |
Agenus | 156.31M |
Sutro Biopharma | 153.73M |
Nektar Therapeutics | 90.12M |
EDAP TMS | 67.14M |
Opthea | 385.28K |
CDXC News
- 16 hours ago - ChromaDex's NIAGEN® (Patented Nicotinamide Riboside, NR), the Most Efficient and High-Quality NAD+ Precursor, Featured in New Solgar® Cellular Nutrition Cellular Energy Supplement - Business Wire
- 5 days ago - ChromaDex Announces Nationwide Launch of Tru Niagen® at The Vitamin Shoppe® - Business Wire
- 6 days ago - ChromaDex to Report First Quarter 2024 Financial Results on Wednesday, May 8, 2024 - Business Wire
- 7 days ago - ChromaDex Announces Inaugural Major Grocery Debut of Tru Niagen® at Sprouts Farmers Market - Business Wire
- 5 weeks ago - ChromaDex Announces Tru Niagen® is Now Third-Party Verified Through the Alkemist Assured™ Transparency Program - Business Wire
- 7 weeks ago - ChromaDex Corporation Reports Fourth Quarter and Fiscal Year 2023 Results - Business Wire
- 2 months ago - ChromaDex to Report Fourth Quarter 2023 Financial Results on Wednesday, March 6, 2024 - Business Wire
- 3 months ago - ChromaDex to Participate in Renmark's Virtual Non-Deal Roadshow on Monday, February 12, 2024 - Business Wire